Scandal fallout lingers: Social media chatter highlights ongoing recovery efforts at UnitedHealth Group following last year's regulatory challenges and medical cost pressures. Analysts and investors note the company's solid revenue base as it adjusts guidance toward more stable single-digit earnings growth.
Long-term holders weigh in: Discussions emphasize patience with the stock, citing its essential role in healthcare and potential to rebound toward prior highs if execution improves. Some participants are actively seeking dividend alternatives with similar cash flow strength to diversify away from recent volatility.
Market reaction observed: Broader sentiment reflects a mix of caution and measured optimism, with focus on turnaround signals in Medicare Advantage operations. Observers point to disciplined cost measures as key to restoring momentum in the coming quarters.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $111.7B in Q1 2026. This is an increase of 1.96% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
You can access data on UNH stock through the Quiver Quantitative API.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 11 times in the past 6 months. Of those trades, 8 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/22 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 3 purchases worth up to $80,000 on 04/14, 03/13, 12/19 and 1 sale worth up to $50,000 on 02/10.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 03/19.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
- REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
UnitedHealth Group Hedge Fund Activity
We have seen 1,339 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,967 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 12,377,403 shares (+146.6%) to their portfolio in Q1 2026, for an estimated $3,327,664,796
- CAPITAL RESEARCH GLOBAL INVESTORS added 10,850,420 shares (+173.3%) to their portfolio in Q1 2026, for an estimated $2,917,135,417
- CAPITAL INTERNATIONAL INVESTORS removed 9,653,799 shares (-51.7%) from their portfolio in Q1 2026, for an estimated $2,595,423,861
- WELLINGTON MANAGEMENT GROUP LLP removed 5,597,135 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $1,504,789,744
- CAPITAL WORLD INVESTORS added 5,192,373 shares (+23.0%) to their portfolio in Q1 2026, for an estimated $1,395,969,481
- BERKSHIRE HATHAWAY INC removed 5,039,564 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,354,886,781
- ROYAL BANK OF CANADA removed 2,749,844 shares (-34.1%) from their portfolio in Q1 2026, for an estimated $739,295,559
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UnitedHealth Group Government Contracts
We have seen $16,208,619,382 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 2ND QTR FEBRUARY: $730,504,137
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $398.5.
Here are some recent targets:
- A.J. Rice from UBS set a target price of $460.0 on 05/22/2026
- Ann Hynes from Mizuho set a target price of $440.0 on 05/20/2026
- Lisa Gill from JP Morgan set a target price of $420.0 on 04/28/2026
- Ryan Langston from TD Cowen set a target price of $337.0 on 04/23/2026
- Michael Ha from Baird set a target price of $287.0 on 04/22/2026
- Michael Wiederhorn from Oppenheimer set a target price of $405.0 on 04/22/2026
- Whit Mayo from Leerink Partners set a target price of $400.0 on 04/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
